Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07825142) titled 'A Randomized, Double-Blind, Placebo-Controlled Trial of Anrikefon for Postoperative Analgesia After Percutaneous Nephrolithotomy' on Sept. 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: Beijing Tsinghua Chang Gung Hospital
Condition:
Postoperative Pain
Nephrolithiasis
Intervention:
Drug: 0.9% Sodium Chloride Injection as Placebo
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 12, 202...